Xanadoo Co. (XAND) Financials Nov 13, 2014, 8:10

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
Xanadoo Co. (XAND) Financials Nov 13, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Xanadoo Co.


Fiscal year is January-December. All values USD millions. 2001 2002 2003 2004 2005 5-year trend
Sales/Revenue 872.55M 901.77M 862.85M 235,000 859,000
Cost of Goods Sold (COGS) incl. D&A 847.82M 813.1M 746.67M 11.84M 17.01M
COGS excluding D&A 577.2M 596.79M 563.18M 950,000 1.44M
Depreciation & Amortization Expense 270.62M 216.31M 183.49M 10.89M 15.57M
Depreciation 15.3M 26.5M 25.7M 1.3M 1.3M
Amortization of Intangibles 255.32M 189.81M 157.79M 9.59M 14.27M
Gross Income 24.74M 88.68M 116.18M (11.6M) (16.15M)
2001 2002 2003 2004 2005 5-year trend
SG&A Expense 219.34M 101.74M 63.42M 13.09M 9.97M
Research & Development 5.37M 18.19M 16.1M 10.56M 4.61M
Other SG&A 213.97M 83.55M 47.32M 2.53M 5.36M
Other Operating Expense 25.73M 14.41M 39.57M 5.3M 737,000
Unusual Expense 55.61M 26.11M 17.13M 22.79M 2.4M
EBIT after Unusual Expense (55.61M) (26.11M) (17.13M) (22.79M) (2.4M)
Non Operating Income/Expense (7.13M) 2.8M 3.1M 212,000 857,000
Non-Operating Interest Income 4.93M 907,000 923,000 802,000 1.38M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 136.3M 145.4M 157.2M 840,000 675,000
Gross Interest Expense 136.3M 145.4M 157.2M 840,000 675,000
Interest Capitalized 0 0 0 - -
Pretax Income (414.45M) (195.27M) (157.11M) (52.61M) (27.69M)
Income Tax (123.52M) (33.13M) 219,000 18,000 30,000
Income Tax - Current Domestic (753,000) 232,000 219,000 18,000 30,000
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (122.77M) (33.36M) 0 0 0
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 14.32M 865,000 (3.67M) 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (276.6M) (161.28M) (160.99M) (52.63M) (27.72M)
Minority Interest Expense 0 0 0 0 0
Net Income (276.6M) (161.28M) (160.99M) (52.63M) (27.72M)
Extraordinaries & Discontinued Operations (1.81M) 7.65M 9.96M (493.88M) 413.13M
Extra Items & Gain/Loss Sale Of Assets (1.81M) 7.65M 9.96M (2.13M) 0
Cumulative Effect - Accounting Chg 0 0 0 (2.13M) 0
Discontinued Operations 0 - - (491.75M) 413.13M
Net Income After Extraordinaries (278.4M) (153.63M) (151.04M) (546.51M) 385.41M
Preferred Dividends 49.84M 31.49M 19.83M 14.34M 12.91M
Net Income Available to Common (326.43M) (192.77M) (180.83M) (66.96M) (40.63M)
EPS (Basic) (2,905.00) (1,612.00) (1,582.50) (4,476.00) 2,856.00
Basic Shares Outstanding 112,424 119,580 114,240 123,230 130,410
EPS (Diluted) (2,903.60) (1,612.04) (1,582.86) (543.41) (311.58)
Diluted Shares Outstanding 112,424 119,580 114,240 123,230 130,410
EBITDA 50.27M 188.84M 196.69M (19.11M) (11.28M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Savvas Launches Miller & Levine Biology Program Revamp

Updated Category News Views 35

Education Meets Innovation: Savvas Takes a Bold Step Who would have thought biology education could get a makeover that might actually stick? Savvas Learning Company thinks it's onto something with the launch of the all-new Miller & Levine Experience Biology Program. The spotlight's on innovation—it's about time someone shook up the way high schoolers learn biology. A...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 88

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
transcosmos: Not Just Calls—Evolving Business Strategy

Updated Category News Views 110

Turning Talk into Triumphs Award chatter isn't exactly rare in this industry, but the latest accolades rolling in for transcosmos from the Best Contact Center Indonesia 2026 ain't your run-of-the-mill pat on the back. Sure, a trophy's a trophy, but when they snatch Gold in the Business Contribution category and another shiny Silver in People Development, it’s hinting at...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
SoftwareOne Triumphs in 2026 GitHub Partner Awards

Updated Category News Views 43

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

Continue Reading
Data Centers Drive Surge in Power and Cooling Demand

Updated Category News Views 23

Data Centers: The Unseen Powerhouses Don't let the tech jargon fool you—data centers are more than just server rooms. They're beastly energy guzzlers, and their demand is rippling through the supply chain in a big way. You've got companies like Vertiv, American Tower, Johnson Controls, and Generac riding high on this trend, making some serious waves in their quarterly...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 28

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Jacobi's Harness Brings AI from Concept to Reality

Updated Category News Views 160

The Challenge of Moving AI to Production Diving headfirst into AI in finance? Well, Jacobi's bold move with their new toy, the Investment Management Harness, spotlights a filthy secret: the hurdles between a big idea and execution are seldom technological. We got AI shaving prototyping time down to just days, yet pushing to production? That's a marathon in itself. Boards...

Continue Reading
Air Canada-CAE Scholarship Drives Women in Aviation

Updated Category News Views 88

A New Chapter for Women in Aviation Call it paving the skies or busting the glass cockpit ceiling, but Air Canada and CAE are really doubling down on getting more women into aviation. They're rolling out the eighth annual Captain Judy Cameron Scholarship, set to open applications on November 1, 2026. With up to eight scholarships on the table for Canadian women eyeing...

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 63

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative AI Assistant by ClickBid Revolutionizes Fundraising

Updated Category News Views 155

ClickBid Introduces Groundbreaking AI Assistant ClickBid, recognized as a pioneer in event fundraising technology, proudly presents ClickBid Search. This is the first custom GPT-powered AI assistant tailored specifically for nonprofits, designed to offer immediate and relevant answers to help organizations optimize their event strategies. Available at no cost to all...

Continue Reading
TIER IV and TUM Drive Level 4 Autonomous Cars

Updated Category News Views 25

Autonomous Driving Gets a German Boost Well folks, looks like the autonomous vehicle scene is hitting the autobahns with more horsepower than ever before. Today’s chatter is all about how TIER IV and the Technical University of Munich (TUM) have teamed up, tapping into the grid as they ride the waves of cutting-edge NVIDIA tech. The Sparks Under the Hood: NVIDIA...

Continue Reading
Vericel Corporation's Upcoming Presentation at MedTech Conference

Updated Category News Views 147

Vericel Corporation's Engagement at the MedTech Conference CAMBRIDGE, Mass. — Vericel Corporation (NASDAQ:VCEL), a recognized leader in advanced therapies for sports medicine and severe burn care, has exciting news regarding its participation at the upcoming Truist Securities MedTech Conference. The company will be featured in a fireside chat, slated to take place at...

Continue Reading
Gildan Achieves Strong Q2 Results: Revenue and Finances Surge

Updated Category News Views 128

Gildan Reports Remarkable Growth in Second Quarter Earnings Gildan Activewear Inc. (NYSE: GIL, TSX: GIL) has achieved record net sales of $919 million during the second quarter, reflecting a strong 6.5% increase compared to the previous year. Strong Operational Performance and Profitability This quarter's operating margin stood at an impressive 21.7%, with an adjusted...

Continue Reading
MimiVax and UI Pharmaceuticals Mark Key Production Milestone

Updated Category News Views 260

MimiVax and UI Pharmaceuticals Mark Key Production Milestone MimiVax and UI Pharmaceuticals have achieved an exciting development in the field of cancer treatment with the clinical manufacture of SurVaxM, an innovative immunotherapeutic vaccine aimed at targeting glioblastoma. SurVaxM proudly stands out as the first product to be manufactured at UI Pharmaceuticals' newly...

Continue Reading